Medicines Patent Pool (MPP), The Lancet Global Health Commissions
Expanding access to biotherapeutics in low-income and middle-income countries through public health non-exclusive voluntary intellectual property licensing: considerations, requirements, and opportunities
Publication
19 Aug 2024
This paper focuses on expanding access to biotherapeutics in low- and middle-income countries (LMICs) through public health non-exclusive voluntary intellectual property licensing.The key elements identified as relevant to support access to affordable biosimilars in LMICs through licensing include:Prioritising potential biotherapeutic targets according to their potential for public health impactSu...